Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Vaxcyte Inc. (PCVX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,377,738 | 0.93 | Add 1.74% | 0.02 | $58.11 | $80,060,355 | SEC |
| 2025 Q4 | 1,354,237 | 0.67 | Add 5.01% | 0.03 | $46.14 | $62,484,495 | SEC |
| 2025 Q3 | 1,289,567 | 0.62 | Reduce 1.61% | 0.01 | $36.02 | $46,450,203 | SEC |
| 2025 Q2 | 1,310,605 | 0.65 | Add 8.49% | 0.05 | $32.51 | $42,607,769 | SEC |
| 2025 Q1 | 1,208,093 | 0.82 | Add 0.52% | <0.01 | $37.76 | $45,617,592 | SEC |
| 2024 Q4 | 1,201,898 | 1.77 | Add 23.11% | 0.33 | $81.86 | $98,387,370 | SEC |
| 2024 Q3 | 976,249 | 2.18 | Add 41.92% | 0.64 | $114.27 | $111,555,973 | SEC |
| 2024 Q2 | 687,908 | 0.99 | Add 93.71% | 0.48 | $75.51 | $51,943,933 | SEC |
| 2024 Q1 | 355,131 | 0.45 | Buy | 0.45 | $68.31 | $24,258,999 | SEC |